Position in EXEL
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$7,452,652
+$2,104,691 QoQ
Shares Held
173,762
+42.4% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $113,232,394 across 120 Biotechnology names. EXEL ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,972 | $24,547,196 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,385 | $12,659,706 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
173,762 | $7,452,652 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
180,285 | $5,989,067 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
80,892 | $5,674,573 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
78,488 | $3,733,674 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,577 | $3,499,611 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,076 | $3,453,265 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,452,652 | 173,762 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,347,961 | 122,016 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,762,516 | 381,659 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $11,736,917 | 266,264 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,992,567 | 243,569 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,635,926 | 139,217 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,665,722 | 141,261 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,195,391 | 142,207 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,038,223 | 128,033 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,950,674 | 122,996 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,632,466 | 120,479 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,213,702 | 115,840 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,153,345 | 110,940 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,588,553 | 99,037 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,316,837 | 83,982 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,533,726 | 73,666 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,633,192 | 72,042 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,310,840 | 71,709 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,601,355 | 75,750 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $908,941 | 49,887 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $754,709 | 33,409 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $871,058 | 43,401 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,278,612 | 52,295 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,192,697 | 50,240 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,022,024 | 59,351 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||